Cargando…

A Decade of Blood Biomarkers for Alzheimer’s Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication

Blood-based biomarkers represent a less invasive and potentially cheaper approach for aiding Alzheimer’s disease (AD) detection compared with cerebrospinal fluid and some neuroimaging biomarkers. Acknowledging that many in the field have made great progress, here we review some of the work that our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Liu, Baird, Alison L., Westwood, Sarah, Hye, Abdul, Dobson, Richard, Thambisetty, Madhav, Lovestone, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870012/ https://www.ncbi.nlm.nih.gov/pubmed/29562526 http://dx.doi.org/10.3233/JAD-170531

Ejemplares similares

Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
por: Baird, Alison L., et al.
Publicado: (2015)

Plasma Biomarkers of Brain Atrophy in Alzheimer's Disease
por: Thambisetty, Madhav, et al.
Publicado: (2011)

A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer’s Disease
por: Khan, Wasim, et al.
Publicado: (2015)

Blood biomarkers for Alzheimer’s disease
por: Lovestone, Simon
Publicado: (2014)

The evolving Indian AIDS epidemic: Hope & challenges of the fourth decade
por: Mayer, Kenneth
Publicado: (2011)

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
por: Westwood, Sarah, et al.
Publicado: (2017)

Midlife anticholinergic drug use, risk of Alzheimer's disease, and brain atrophy in community-dwelling older adults
por: Chuang, Yi-Fang, et al.
Publicado: (2017)

Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study
por: Snowden, Stuart G., et al.
Publicado: (2017)

Alzheimer’s Disease, Diagnosis and the Need for Biomarkers
por: Hooper, Claudie, et al.
Publicado: (2008)

Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer’s Disease
por: Kim, Min, et al.
Publicado: (2017)

Genetic Variation in Targets of Antidiabetic Drugs and Alzheimer Disease Risk: A Mendelian Randomization Study
por: Tang, Bowen, et al.
Publicado: (2022)

Systematic Identification of circRNAs in Alzheimer’s Disease
por: Cochran, Kyle R., et al.
Publicado: (2021)

Metabolomic Method: UPLC-q-ToF Polar and Non-Polar Metabolites in the Healthy Rat Cerebellum Using an In-Vial Dual Extraction
por: Ebshiana, Amera A., et al.
Publicado: (2015)

Plasma Based Markers of [(11)C] PiB-PET Brain Amyloid Burden
por: Kiddle, Steven John, et al.
Publicado: (2012)

ANMerge: A Comprehensive and Accessible Alzheimer’s Disease Patient-Level Dataset
por: Birkenbihl, Colin, et al.
Publicado: (2021)

Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging
por: Gupta, Veer Bala, et al.
Publicado: (2015)

Pulmonary Vein Stenosis—Evolving Surgical Management of a Challenging Disease
por: Feins, Eric N., et al.
Publicado: (2021)

Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer’s disease
por: Startin, Carla M., et al.
Publicado: (2019)

Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer’s disease brain proteomic signature
por: Roberts, Jackson A., et al.
Publicado: (2023)

Evolving liver transplantation in Pakistan: Future challenges
por: Dogar, Abdul Wahab, et al.
Publicado: (2022)

Prostate cancer in East Asia: evolving trend over the last decade
por: Zhu, Yao, et al.
Publicado: (2015)

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
por: Bos, Isabelle, et al.
Publicado: (2018)

The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
por: Simrén, Joel, et al.
Publicado: (2021)

Alzheimer’s Disease Biomarker Detection Using Field Effect Transistor-Based Biosensor
por: Le, Phan Gia, et al.
Publicado: (2023)

Mobile DNA: an evolving field
por: Belfort, Marlene, et al.
Publicado: (2014)

Telemedicine: An Evolving Field in Hepatology
por: Piao, Cindy, et al.
Publicado: (2019)

The Evolving Field of Risk Communication
por: Balog‐Way, Dominic, et al.
Publicado: (2020)

Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge
por: Zanni, Riccardo, et al.
Publicado: (2018)

Brain Inflammation and Seizures: Evolving Concepts and New Findings in the Last 2 Decades
por: Vezzani, Annamaria
Publicado: (2020)

Revisiting the gonadotropic regulation of mammalian spermatogenesis: evolving lessons during the past decade
por: Bhattacharya, Indrashis, et al.
Publicado: (2023)

Evolving landscape of clinical trials in gastroenteropancreatic neuroendocrine neoplasms in the past two decades
por: Yang, Kaili, et al.
Publicado: (2023)

Current Issues in Molecular Biology Keep Evolving and Getting Better
por: Bhatia, Madhav
Publicado: (2023)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades
por: Teng-Fei, Sun, et al.
Publicado: (2022)

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
por: Stamate, Daniel, et al.
Publicado: (2019)

Sepsis: evolving concepts and challenges
por: Salomão, R., et al.
Publicado: (2019)

Challenges in the Evolving CME Landscape
por: Gillgrass, Darren
Publicado: (2020)

Inflammatory biomarkers in Alzheimer's disease plasma
por: Morgan, Angharad R., et al.
Publicado: (2019)

NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
por: Rojo, Ana I., et al.
Publicado: (2017)

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer’s Disease Multimodal Biomarker Discovery Cohort
por: Westwood, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8g3ma09831eueuh487lp18fdfk